Contact Molecules for Homologous Proteins | ||||
[Full Bars] |
[SiteTable] |
|
[Back to Search Page] |
[Back to HOMCOS] |
[SupCon3D] |
[help] |
seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100] | [show] [download] [help] |
PID | QueryLength | Homolgous Sequence in PDB | UniProt Query | TITLE |
24430 | 805 | 598 | Q9BYF1(ACE2_HUMAN) | RecName: Full=Angiotensin-converting enzyme 2; EC=3.4.17.23 ;AltName: Full=Angiotensin-converting enzyme homolog ; Short=ACEH ;AltName: Full=Angiotensin-converting enzyme-related carboxypeptidase ; Short=ACE-related carboxypeptidase; EC=3.4.17.- ;AltName: Full=Metalloprotease MPROT15 ;Contains: RecName: Full=Processed angiotensin-converting enzyme 2 ;Flags: Precursor; |
QUERYSEQ |
MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQALQQNGSSVLSEDKSKRLNTILNTMSTIYSTGKVCNPDNPQECLLLEPGLNE IMANSLDYNERLWAWESWRSEVGKQLRPLYEEYVVLKNEMARANHYEDYGDYWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHLHAYVRAKLMNAYPSYISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQ AWDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWDLGKGDFRILMCTKVTMDDFLTAHHEMGHIQYDMAYAAQPFLLRNGANEGFHEAVGEIMSLSAATPKHLKSIGLLSPDFQEDNETEINFLLKQALTIVGTL PFTYMLEKWRWMVFKGEIPKDQWMKKWWEMKREIVGVVEPVPHDETYCDPASLFHVSNDYSFIRYYTRTLYQFQFQEALCQAAKHEGPLHKCDISNSTEAGQKLFNMLRLGKSEPWTLALENVVGAKNMNVRPLLNYFEPLFTWLKDQNK NSFVGWSTDWSPYADQSIKVRISLKSALGDKAYEWNDNEMYLFRSSVAYAMRQYFLKVKNQMILFGEEDVRVANLKPRISFNFFVTAPKNVSDIIPRTEVEKAIRMSRSRINDAFRLNDNSLEFLGIQPTLGPPNQPPVSIWLIVFGVVM GVIVVGIVILIFTGIRDRKKKNKARSGENPYASIDISKGENNPGFQNTDDVQTSF |
805 | region | name | description |
1-17 | SIGNAL | ||
18-805 | CHAIN | /note="Angiotensin-converting enzyme 2" /id="PRO_0000028570" | |
18-708 | CHAIN | /note="Processed angiotensin-converting enzyme 2" /id="PRO_0000292268" | |
18-740 | TOPO_DOM | /note="Extracellular" | |
741-761 | TRANSMEM | /note="Helical" | |
762-805 | TOPO_DOM | /note="Cytoplasmic" | |
19-607 | DOMAIN | /note="Peptidase M2" | |
614-805 | DOMAIN | /note="Collectrin-like" | |
30-41 | REGION | /note="Interaction with SARS-CoV spike glycoprotein" | |
82-84 | REGION | /note="Interaction with SARS-CoV spike glycoprotein" | |
353-357 | REGION | /note="Interaction with SARS-CoV spike glycoprotein" | |
652-659 | REGION | /note="Essential for cleavage by ADAM17" | |
697-716 | REGION | /note="Essential for cleavage by TMPRSS11D and TMPRSS2" | |
772-805 | REGION | /note="Disordered" | |
785-805 | COMPBIAS | /note="Polar residues" | |
375-375 | ACT_SITE | /note="Proton acceptor" ECO:0000305|PubMed:14754895, ECO:0000305|PubMed:27217402" | |
505-505 | ACT_SITE | /note="Proton donor" ECO:0000305|PubMed:14754895" | |
169-169 | BINDING | /ligand="chloride" /ligand_id="ChEBI:CHEBI:17996" ECO:0000269|PubMed:14754895, ECO:0000305|PubMed:19021774" | |
273-273 | BINDING | /ligand="substrate" | |
345-346 | BINDING | /ligand="substrate" | |
374-374 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" /ligand_note="catalytic" ECO:0000269|PubMed:14754895" | |
378-378 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" /ligand_note="catalytic" ECO:0000269|PubMed:14754895" | |
402-402 | BINDING | /ligand="Zn(2+)" /ligand_id="ChEBI:CHEBI:29105" /ligand_note="catalytic" ECO:0000269|PubMed:14754895" | |
477-477 | BINDING | /ligand="chloride" /ligand_id="ChEBI:CHEBI:17996" ECO:0000269|PubMed:14754895, ECO:0000305|PubMed:19021774" | |
481-481 | BINDING | /ligand="chloride" /ligand_id="ChEBI:CHEBI:17996" ECO:0000269|PubMed:14754895, ECO:0000305|PubMed:19021774" | |
515-515 | BINDING | /ligand="substrate" | |
1-805 | DISORDER | predicted by DISOPRED |
MONOMER | |||||||
805 | |||||||
pdb_id | a1 | identity[%]2 | description | ||||
7v61 | B | 100.0 | ACE2_HUMAN Angiotensin-converting enzyme 2 | ||||
1.a1:asym_id for the homologue. 2.identity[%]2:sequence identity between the query and the homologue. |
HETERO | |||||||
805 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
1r42[2] | B | disordered segment of collectrin homology domain[6.. | A | 100.0 /100.0 |
2 /2 |
angiotensin I converting enzyme 2 | |
1r42[2] | C | disordered segment of collectrin homology domain[2.. | A | 100.0 /100.0 |
2 /2 |
angiotensin I converting enzyme 2 | |
1r42[2] | E | disordered segment of collectrin homology domain[1.. | A | 100.0 /100.0 |
3 /3 |
angiotensin I converting enzyme 2 | |
3kbh[4] | B | SPIKE_CVHNL Spike glycoprotein[110 aa] | A | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6acg[4] | C | SPIKE_CVHSA Spike glycoprotein[1057 aa] | D | 100.0 /100.0 |
18 /18 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6m17[12] | A | S6A19_HUMAN Sodium-dependent neutral amino acid transporter B(.. | B | 100.0 /100.0 |
24 /24 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8i93[2] | B | S6A19_HUMAN Sodium-dependent neutral amino acid transporter B(.. | A | 100.0 /100.0 |
21 /21 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7a92[2] | B | SPIKE_SARS2 Spike glycoprotein[643 aa] | A | 100.0 /100.0 |
18 /18 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7a94[177] | A | SPIKE_SARS2 Spike glycoprotein[1080 aa] | D | 100.0 /100.0 |
15 /15 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7dwx[11] | E | SPIKE_SARS2 Spike glycoprotein[1007 aa] | B | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7xob[2] | A | SPIKE_SARS2 Spike glycoprotein[1026 aa] | E | 100.0 /84.3 |
1 /1 |
ACE2_MOUSE Angiotensin-converting enzyme 2 | |
7yr3[2] | A | SPIKE_SARS2 Spike glycoprotein[1058 aa] | C | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7bh9[1] | B | SPIKE_SARS2 Spike protein S1[144 aa] | A | 100.0 /100.0 |
16 /16 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7ddp[3] | B | A0A6G6A1M4_9BETC Spike protein S1[194 aa] | A | 100.0 /100.0 |
18 /18 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7e7e[2] | B | h11B11-Fab[208 aa] | A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7e7e[1] | C | h11B11-Fab[210 aa] | A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7e7e[1] | F | h11B11-Fab[210 aa] | D | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7t9l[42] | A | SPIKE_SARS2 Spike glycoprotein[201 aa] | B | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7wk6[15] | A | SPIKE_SARS2 Spike glycoprotein[194 aa] | B | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7y75[8] | C | SPIKE_SARS2 Spike protein S1[198 aa] | B | 100.0 /100.0 |
16 /16 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7v61[2] | C | 3E8[223 aa] | B | 100.0 /100.0 |
12 /12 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7v61[2] | D | 3E8[214 aa] | B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7xbf[5] | B | RshSTT182/200 coronavirus receptor binding domain .. | A | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7y75[6] | A | S6A20_HUMAN Sodium- and chloride-dependent transporter XTRP3[5.. | B | 100.0 /100.0 |
19 /19 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8b9p[2] | C | ALA-CYS-GLY-ARG-GLN-PHE-CYS-HIS-THR-LEU-MET-PRO-AR.. | A | 100.0 /100.0 |
34 /34 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8bfw[4] | B | ALA-CYS-VAL-ARG-SER-HIS-CYS-SER-SER-LEU-LEU-PRO-AR.. | A | 100.0 /100.0 |
33 /33 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8bn1[2] | D | ALA-CYS-VAL-ARG-SER-4PH-CYS-SER-SER-LEU-LEU-PRO-AR.. | A | 100.0 /100.0 |
33 /33 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8e7m[1] | B | 05B04 Heavy Chain[218 aa] | A | 100.0 /100.0 |
8 /8 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8e7m[1] | C | 05B04 Light Chain[214 aa] | A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8fxb[1] | D | SPIKE_SARS2 Spike protein S1[162 aa] | C | 100.0 /100.0 |
16 /16 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8i9e[2] | B | SPIKE_SARS2 Spike protein S1[167 aa] | A | 100.0 /100.0 |
13 /13 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8toq[1] | B | Peptide 1[13 aa] | A | 100.0 /100.0 |
20 /20 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8tor[4] | B | Peptide 2[15 aa] | A | 100.0 /100.0 |
25 /25 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8tos[1] | B | Peptide 6[12 aa] | A | 100.0 /100.0 |
19 /19 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6vw1[14] | C | SPIKE_CVHSA SPIKE_SARS2 SPIKE_CVHSA SARS-CoV-2 chimeric RBD[193 aa] | A | 100.0 /100.0 |
21 /21 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7drv[3] | B | A0A6B9WHD3_SARS Spike glycoprotein[195 aa] | A | 100.0 /100.0 |
16 /16 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7p8i[4] | B | A0A6B9WHD3_SARS Spike glycoprotein[193 aa] | A | 100.0 /100.0 |
13 /13 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7fc3[1] | A | SPIKE_CVHNL Spike protein S1[131 aa] | B | 87.5 /87.4 |
16 /16 |
F6V9L3_HORSE Angiotensin-converting enzyme | |
6lzg[64] | B | SPIKE_SARS2 Spike protein S1[195 aa] | A | 100.0 /100.0 |
20 /20 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6m17[31] | C | SPIKE_SARS2 Spike protein S1[183 aa] | B | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8aqt[1] | B | SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin[193 aa] | A | 42.9 /84.5 |
7 /7 |
ACE2_MOUSE GCAM_MOUSE Processed angiotensin-converting enzyme 2,Ig gamma.. | |
2ajf[18] | C | SPIKE_CVHSA SARS-coronavirus spike protein[174 aa] | A | 100.0 /100.0 |
20 /20 |
ACE2_HUMAN Angiotensin-converting enzyme-Related Carboxypepti.. | |
7wsf[2] | B | SPIKE_SARS Spike protein S1[186 aa] | A | 80.0 /83.4 |
20 /20 |
A0A452CBT6_BALAS Angiotensin-converting enzyme | |
8u0t[1] | B | PRD-0038[174 aa] | A | 56.2 /79.7 |
16 /16 |
A0A0N7IQX6_RHIAY Angiotensin-converting enzyme | |
8hxk[1] | B | A0A7D6P0R3_9BETC Spike glycoprotein[676 aa] | A | 78.9 /79.6 |
19 /19 |
A0A7D7J6S6_RHIAI Angiotensin-converting enzyme | |
7wpz[1] | B | A0A1W6ASU7_9NIDO Spike glycoprotein[192 aa] | A | 64.3 /78.5 |
14 /14 |
A0A7J7V5I6_PIPKU Angiotensin-converting enzyme | |
7wpo[1] | B | U5NJG5_MERS Spike glycoprotein[187 aa] | A | 61.5 /78.2 |
13 /13 |
A0A7J7V5I6_PIPKU Angiotensin-converting enzyme | |
8qfx[4] | G | ILE-PRO-PRO[3 aa] | A | 61.5 /43.7 |
13 /13 |
ACE_HUMAN Angiotensin-converting enzyme, soluble form | |
8qhl[2] | B | VAL-PRO-PRO[3 aa] | A | 57.1 /43.6 |
14 /14 |
ACE_HUMAN Angiotensin-converting enzyme | |
6qs1[1] | D | Bradykinin potentiating peptide b[5 aa] | B | 60.0 /43.6 |
20 /20 |
ACE_HUMAN Angiotensin-converting enzyme | |
4aph[1] | B | ANGT_HUMAN ANGIOTENSIN-2[8 aa] | A | 50.0 /43.6 |
22 /22 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
4apj[1] | B | BNP_GLOBL BRADYKININ-POTENTIATING PEPTIDE B[11 aa] | A | 28.6 /43.6 |
28 /28 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
6qs1[1] | C | Bradykinin potentiating peptide b[11 aa] | A | 51.4 /43.5 |
37 /38 |
ACE_HUMAN Angiotensin-converting enzyme | |
5am8[4] | E | A4_HUMAN BETA-AMYLOID PROTEIN 42[3 aa] | A | 54.5 /43.6 |
11 /11 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
5amb[2] | C | A4_HUMAN AMYLOID BETA A4 PROTEIN[2 aa] | A | 54.5 /43.4 |
11 /11 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
4aa1[1] | B | ANGT_HUMAN ANGIOTENSIN-2[5 aa] | A | 50.0 /37.7 |
20 /20 |
ACE_DROME ANGIOTENSIN-CONVERTING ENZYME | |
4aa2[1] | B | BNP_GLOBL BRADYKININ-POTENTIATING PEPTIDE B[6 aa] | A | 57.1 /37.7 |
21 /21 |
ACE_DROME ANGIOTENSIN-CONVERTING ENZYME | |
4asq[2] | B | KNG1_HUMA BRADYKININ[4 aa] | A | 53.3 /37.7 |
15 /15 |
ACE_DROME ANGIOTENSIN-CONVERTING ENZYME | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
COMPOUND | |||||||
805 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
1o8a[875] | B |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 60.0 /43.7 |
5 /5 |
ACET_HUMAN ANGIOTENSIN CONVERTING ENZYME | |
1o8a[3] | C |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 0.0 /43.7 |
1 /1 |
ACET_HUMAN ANGIOTENSIN CONVERTING ENZYME | |
1o8a[138] | D |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 50.0 /43.7 |
2 /2 |
ACET_HUMAN ANGIOTENSIN CONVERTING ENZYME | |
1o8a[9] | E |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 0.0 /43.7 |
3 /3 |
ACET_HUMAN ANGIOTENSIN CONVERTING ENZYME | |
1o8a[1] | F |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 0.0 /43.7 |
1 /1 |
ACET_HUMAN ANGIOTENSIN CONVERTING ENZYME | |
1o8a[2] | G |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /43.7 |
1 /1 |
ACET_HUMAN ANGIOTENSIN CONVERTING ENZYME | |
2c6f[71] | G |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 80.0 /44.3 |
5 /5 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME, SOMATIC ISOFORM | |
3bkk[2] | D |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[15 atoms].. |
A | 33.3 /43.1 |
6 /6 |
ACE_HUMAN Angiotensin-converting enzyme, somatic isoform | |
4bxk[9] | T |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
B | 33.3 /43.4 |
3 /3 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
7a91[8] | H |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7edj[21] | GB |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
D | 100.0 /100.0 |
2 /2 |
Angiotensin-converting enzyme 2 (ACE2) ectodomain | |
7efp[2] | E |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 100.0 /99.8 |
4 /4 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7f5r[3] | N |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
C | 66.7 /84.1 |
3 /3 |
mink ACE2 | |
7q3y[2] | M |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 0.0 /43.3 |
2 /2 |
ACE_HUMAN Angiotensin-converting enzyme | |
7q3y[2] | N |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 0.0 /43.3 |
2 /2 |
ACE_HUMAN Angiotensin-converting enzyme | |
7wpo[2] | J |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
A | 80.0 /78.2 |
5 /5 |
A0A7J7V5I6_PIPKU Angiotensin-converting enzyme | |
7xid[2] | KB |
NAG
2-acetamido-2-deoxy-beta-D-glucopyranose[14 atoms].. |
D | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
1r4l[1] | J |
XX5
(S,S)-2-{1-CARBOXY-2-[3-(3,5-DICHLORO-BENZYL)-3H-I.. |
A | 100.0 /100.0 |
16 /16 |
ACE2_HUMAN angiotensin I converting enzyme 2 | |
6m18[6] | W |
3PH
1,2-DIACYL-GLYCEROL-3-SN-PHOSPHATE[48 atoms] |
B | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8b9p[2] | E |
LFI
1-[3,5-bis(3-bromanylpropanoyl)-1,3,5-triazinan-1-.. |
A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8bfw[6] | E |
LFI
1-[3,5-bis(3-bromanylpropanoyl)-1,3,5-triazinan-1-.. |
A | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
3d0g[6] | E |
NDG
2-acetamido-2-deoxy-alpha-D-glucopyranose[15 atoms.. |
A | 100.0 /98.5 |
3 /3 |
ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2 | |
3d0g[3] | I |
NDG
2-acetamido-2-deoxy-alpha-D-glucopyranose[15 atoms.. |
B | 100.0 /98.5 |
1 /1 |
ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2 | |
3d0g[3] | J |
NDG
2-acetamido-2-deoxy-alpha-D-glucopyranose[15 atoms.. |
B | 100.0 /98.5 |
3 /3 |
ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2 | |
2xhm[1] | C |
K26
N-ACETYL-L-ILE-L-TYR-(R)-1-AMINO-2-(4-HYDROXYPHENY.. |
A | 63.2 /37.7 |
19 /19 |
ACE_DROME ANGIOTENSIN CONVERTING ENZYME | |
4bzr[1] | E |
K26
N-ACETYL-L-ILE-L-TYR-(R)-1-AMINO-2-(4-HYDROXYPHENY.. |
A | 64.7 /43.6 |
17 /17 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
4bzs[2] | N |
K26
N-ACETYL-L-ILE-L-TYR-(R)-1-AMINO-2-(4-HYDROXYPHENY.. |
A | 78.6 /44.1 |
14 /15 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
4bzs[2] | O |
9X6
thiodiglycolic acid[9 atoms] |
A | 40.0 /44.1 |
5 /5 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
4bxk[4] | L |
1IU
[3-[[(2S)-1-azanyl-1-oxidanylidene-propan-2-yl]ami.. |
A | 58.8 /43.4 |
17 /17 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
6en5[1] | GA |
PE3
3,6,9,12,15,18,21,24,27,30,33,36,39-TRIDECAOXAHENT.. |
A | 40.0 /43.8 |
10 /10 |
ACE_HUMAN Angiotensin-converting enzyme | |
8qfx[1] | T |
12P
DODECAETHYLENE GLYCOL[37 atoms] |
A | 37.5 /43.7 |
8 /8 |
ACE_HUMAN Angiotensin-converting enzyme, soluble form | |
6en6[1] | WA |
2PE
NONAETHYLENE GLYCOL[28 atoms] |
B | 20.0 /43.7 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme | |
6f9r[2] | CA |
PE8
3,6,9,12,15,18,21-HEPTAOXATRICOSANE-1,23-DIOL[25 a.. |
B | 37.5 /43.5 |
8 /8 |
ACE_HUMAN Angiotensin-converting enzyme | |
1uzf[1] | E |
MCO
1-(3-MERCAPTO-2-METHYL-PROPIONYL)-PYRROLIDINE-2-CA.. |
A | 58.3 /43.7 |
12 /12 |
ACET_HUMAN ANGIOTENSIN CONVERTING ENZYME | |
6en5[7] | ZB |
XPE
3,6,9,12,15,18,21,24,27-NONAOXANONACOSANE-1,29-DIO.. |
D | 37.5 /43.6 |
8 /8 |
ACE_HUMAN Angiotensin-converting enzyme | |
8qfx[1] | U |
XPE
3,6,9,12,15,18,21,24,27-NONAOXANONACOSANE-1,29-DIO.. |
A | 22.2 /43.7 |
9 /9 |
ACE_HUMAN Angiotensin-converting enzyme, soluble form | |
6en6[1] | AA |
BCN
BICINE[11 atoms] |
A | 0.0 /43.8 |
1 /1 |
ACE_HUMAN Angiotensin-converting enzyme | |
6tt3[5] | U |
BCN
BICINE[11 atoms] |
A | 75.0 /43.3 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
6zpq[8] | M |
BCN
BICINE[11 atoms] |
A | 42.9 /43.6 |
7 /7 |
ACE_HUMAN Angiotensin-converting enzyme | |
6zpq[1] | O |
BCN
BICINE[11 atoms] |
A | 100.0 /43.6 |
1 /1 |
ACE_HUMAN Angiotensin-converting enzyme | |
8qhl[1] | W |
BCN
BICINE[11 atoms] |
C | 66.7 /43.6 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
8qfx[4] | GA |
BMA
beta-D-mannopyranose[11 atoms] |
A | 100.0 /43.7 |
1 /1 |
ACE_HUMAN Angiotensin-converting enzyme, soluble form | |
8qfx[2] | AB |
FUC
alpha-L-fucopyranose[10 atoms] |
B | 0.0 /43.6 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme, soluble form | |
4ufa[6] | N |
ASP
ASPARTIC ACID[9 atoms] |
A | 42.9 /43.4 |
7 /7 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
5am9[2] | AA |
VAL
VALINE[8 atoms] |
B | 37.5 /43.6 |
8 /8 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
5am9[2] | Z |
GLU
GLUTAMIC ACID[9 atoms] |
B | 85.7 /43.6 |
7 /7 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
5ama[4] | P |
SER
SERINE[7 atoms] |
A | 42.9 /43.6 |
7 /7 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
6f9t[1] | E |
D0Z
Sampatrilat[40 atoms] |
A | 47.1 /43.2 |
17 /17 |
ACE_HUMAN Angiotensin-converting enzyme | |
6f9v[2] | F |
D0Z
Sampatrilat[40 atoms] |
A | 52.4 /43.5 |
21 /21 |
ACE_HUMAN Angiotensin-converting enzyme | |
6s1z[1] | C |
KS8
fosinoprilat[30 atoms] |
A | 50.0 /39.6 |
16 /16 |
A0NFU8_ANOGA Angiotensin-converting enzyme | |
7z6z[2] | H |
KS8
fosinoprilat[30 atoms] |
A | 55.0 /43.6 |
20 /20 |
ACE_HUMAN Angiotensin-converting enzyme, soluble form | |
7z70[1] | C |
KS8
fosinoprilat[30 atoms] |
A | 55.6 /43.5 |
18 /18 |
ACE_HUMAN Angiotensin-converting enzyme | |
4ufa[2] | M |
SAC
N-ACETYL-SERINE[9 atoms] |
A | 85.7 /43.4 |
7 /7 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
4ufb[6] | Q |
LYS
LYSINE[9 atoms] |
A | 85.7 /43.6 |
7 /7 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
4ufb[4] | R |
PRO
PROLINE[8 atoms] |
A | 50.0 /43.6 |
8 /8 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
5am9[2] | Q |
GLN
GLUTAMINE[9 atoms] |
A | 85.7 /43.6 |
7 /7 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
5amc[2] | J |
NIY
META-NITRO-TYROSINE[16 atoms] |
A | 25.0 /43.6 |
8 /8 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
3l3n[1] | F |
LSW
N~2~-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-try.. |
A | 50.0 /43.4 |
20 /20 |
ACE_HUMAN Angiotensin-converting enzyme | |
2x97[1] | C |
RX4
N~2~-acetyl-N-{(1R)-1-[(S)-[(2S)-3-{[(2S)-1-amino-.. |
A | 50.0 /37.7 |
18 /18 |
ACE_DROME ANGIOTENSIN CONVERTING ENZYME | |
3nxq[2] | J |
RX4
N~2~-acetyl-N-{(1R)-1-[(S)-[(2S)-3-{[(2S)-1-amino-.. |
A | 52.6 /43.4 |
19 /19 |
ACE_HUMAN Angiotensin-converting enzyme | |
1j37[2] | D |
X8Z
L-CAPTOPRIL[14 atoms] |
A | 58.3 /37.6 |
12 /12 |
ACE_DROME angiotensin converting enzyme | |
2x8z[1] | C |
X8Z
L-CAPTOPRIL[14 atoms] |
A | 58.3 /37.7 |
12 /12 |
ACE_DROME ANGIOTENSIN CONVERTING ENZYME | |
4c2p[1] | F |
X8Z
L-CAPTOPRIL[14 atoms] |
A | 58.3 /43.4 |
12 /12 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
6en5[10] | R |
BJ2
(2~{S})-1-[(2~{S})-2-[[(1~{S})-1-[(2~{S})-1-[(2~{S.. |
A | 58.8 /43.8 |
17 /17 |
ACE_HUMAN Angiotensin-converting enzyme | |
6h5w[1] | G |
FT8
Omapatrilat[27 atoms] |
A | 53.3 /43.2 |
15 /15 |
ACE_HUMAN Angiotensin-converting enzyme | |
6h5w[1] | H |
FT8
Omapatrilat[27 atoms] |
A | 27.3 /43.2 |
11 /11 |
ACE_HUMAN Angiotensin-converting enzyme | |
6h5w[1] | I |
FT8
Omapatrilat[27 atoms] |
A | 10.0 /43.2 |
10 /10 |
ACE_HUMAN Angiotensin-converting enzyme | |
6h5x[4] | J |
FT8
Omapatrilat[27 atoms] |
A | 60.0 /43.6 |
15 /15 |
ACE_HUMAN Angiotensin-converting enzyme | |
6zpt[1] | J |
PG0
2-(2-METHOXYETHOXY)ETHANOL[8 atoms] |
A | 0.0 /43.3 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
6zpt[1] | K |
PG0
2-(2-METHOXYETHOXY)ETHANOL[8 atoms] |
A | 0.0 /43.3 |
1 /1 |
ACE_HUMAN Angiotensin-converting enzyme | |
6zpt[1] | S |
PG0
2-(2-METHOXYETHOXY)ETHANOL[8 atoms] |
B | 100.0 /43.3 |
2 /2 |
ACE_HUMAN Angiotensin-converting enzyme | |
1o8a[2] | J |
NXA
N-CARBOXYALANINE[9 atoms] |
A | 50.0 /43.7 |
8 /8 |
ACET_HUMAN ANGIOTENSIN CONVERTING ENZYME | |
4c2o[1] | G |
MLA
MALONIC ACID[7 atoms] |
A | 66.7 /43.3 |
9 /9 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
7q25[2] | G |
8J9
(2~{S})-2-[[(2~{S})-1-[[(2~{S})-3-(4-hydroxyphenyl.. |
A | 50.0 /43.5 |
18 /18 |
ACE_HUMAN Angiotensin-converting enzyme | |
7q28[1] | E |
8J9
(2~{S})-2-[[(2~{S})-1-[[(2~{S})-3-(4-hydroxyphenyl.. |
A | 44.4 /43.2 |
18 /18 |
ACE_HUMAN Angiotensin-converting enzyme | |
7q26[2] | H |
8JV
(2~{S},5~{R})-5-(4-methylphenyl)-1-[2-[[(2~{S})-1-.. |
A | 55.6 /43.6 |
18 /18 |
ACE_HUMAN Angiotensin-converting enzyme | |
7q29[1] | I |
8JV
(2~{S},5~{R})-5-(4-methylphenyl)-1-[2-[[(2~{S})-1-.. |
A | 44.4 /43.2 |
18 /18 |
ACE_HUMAN Angiotensin-converting enzyme | |
3bkl[1] | K |
KAW
N-{(5S)-4,4-dihydroxy-6-phenyl-5-[(phenylcarbonyl).. |
A | 52.6 /43.1 |
19 /19 |
ACE_HUMAN Angiotensin-converting enzyme, somatic isoform | |
3bkk[1] | H |
KAF
N-{(5S)-4,4-dihydroxy-6-phenyl-5-[(phenylcarbonyl).. |
A | 52.6 /43.1 |
19 /19 |
ACE_HUMAN Angiotensin-converting enzyme, somatic isoform | |
6f9r[2] | J |
D0W
Sampatrilat-Asp[38 atoms] |
A | 50.0 /43.4 |
18 /18 |
ACE_HUMAN Angiotensin-converting enzyme | |
6f9u[1] | H |
D0W
Sampatrilat-Asp[38 atoms] |
A | 50.0 /43.1 |
18 /18 |
ACE_HUMAN Angiotensin-converting enzyme | |
7q24[2] | S |
8KC
(2~{S})-2-[[(2~{S})-1-[[(2~{S})-3-(1~{H}-indol-3-y.. |
A | 45.0 /43.4 |
20 /20 |
ACE_HUMAN Angiotensin-converting enzyme | |
7q27[1] | I |
8KC
(2~{S})-2-[[(2~{S})-1-[[(2~{S})-3-(1~{H}-indol-3-y.. |
A | 47.1 /43.1 |
17 /17 |
ACE_HUMAN Angiotensin-converting enzyme | |
6s1y[1] | H |
KSN
(2~{S})-2-[[(4~{S})-4-azanyl-5-oxidanyl-5-oxidanyl.. |
A | 50.0 /39.3 |
14 /14 |
A0NFU8_ANOGA Angiotensin-converting enzyme | |
1j36[2] | D |
LPR
[N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-LYSYL-L-PROLI.. |
A | 50.0 /37.6 |
16 /16 |
ACE_DROME angiotensin converting enzyme | |
1o86[1] | D |
LPR
[N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-LYSYL-L-PROLI.. |
A | 52.9 /43.7 |
17 /17 |
ACET_HUMAN ANGIOTENSIN CONVERTING ENZYME | |
2c6n[2] | I |
LPR
[N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-LYSYL-L-PROLI.. |
A | 50.0 /44.3 |
14 /14 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME, SOMATIC ISOFORM | |
2x91[1] | C |
LPR
[N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-LYSYL-L-PROLI.. |
A | 50.0 /37.7 |
16 /16 |
ACE_DROME ANGIOTENSIN CONVERTING ENZYME | |
1uze[1] | F |
EAL
1-((2S)-2-{[(1S)-1-CARBOXY-3-PHENYLPROPYL]AMINO}PR.. |
A | 53.3 /43.7 |
15 /15 |
ACET_HUMAN ANGIOTENSIN CONVERTING ENZYME | |
2x90[1] | E |
EAL
1-((2S)-2-{[(1S)-1-CARBOXY-3-PHENYLPROPYL]AMINO}PR.. |
A | 50.0 /37.7 |
14 /14 |
ACE_DROME ANGIOTENSIN CONVERTING ENZYME | |
2oc2[1] | E |
RX3
N-({(1S,2R)-2-[(S)-[(1R)-1-{[(BENZYLOXY)CARBONYL]A.. |
A | 52.6 /43.3 |
19 /19 |
ACE_HUMAN Angiotensin-converting enzyme, somatic isoform | |
2x96[1] | C |
RX3
N-({(1S,2R)-2-[(S)-[(1R)-1-{[(BENZYLOXY)CARBONYL]A.. |
A | 45.5 /37.7 |
22 /22 |
ACE_DROME ANGIOTENSIN CONVERTING ENZYME | |
2x92[1] | G |
X92
RAMIPRILAT[28 atoms] |
A | 50.0 /37.7 |
14 /14 |
ACE_DROME ANGIOTENSIN CONVERTING ENZYME | |
2x93[1] | H |
X93
TRANDOLAPRILAT[29 atoms] |
A | 41.2 /37.7 |
17 /17 |
ACE_DROME ANGIOTENSIN CONVERTING ENZYME | |
2x94[1] | G |
X94
PERINDOPRILAT[24 atoms] |
A | 53.8 /37.7 |
13 /13 |
ACE_DROME ANGIOTENSIN CONVERTING ENZYME | |
2x95[1] | I |
X95
(S)-1-N2-(1-CARBOXY-3-PHENYLPROPYL)-L-LYSYL-L-TRYP.. |
A | 44.4 /37.7 |
18 /18 |
ACE_DROME ANGIOTENSIN CONVERTING ENZYME | |
2xy9[1] | I |
3ES
[(2S)-2-({3-[HYDROXYL(2-PHENYL-(1R)-1-{[(BENZYLOXY.. |
A | 45.5 /43.6 |
22 /22 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
2xy9[1] | J |
3ES
[(2S)-2-({3-[HYDROXYL(2-PHENYL-(1R)-1-{[(BENZYLOXY.. |
A | 21.1 /43.6 |
19 /19 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
2xyd[2] | I |
3ES
[(2S)-2-({3-[HYDROXYL(2-PHENYL-(1R)-1-{[(BENZYLOXY.. |
A | 56.5 /43.4 |
23 /23 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
4ca8[1] | C |
3ES
[(2S)-2-({3-[HYDROXYL(2-PHENYL-(1R)-1-{[(BENZYLOXY.. |
A | 45.8 /37.7 |
24 /24 |
ACE_DROME ANGIOTENSIN-CONVERTING ENZYME | |
2ydm[1] | G |
SLC
SELENO-CAPTOPRIL[14 atoms] |
A | 58.3 /43.7 |
12 /12 |
ACE_HUMAN ANGIOTENSIN CONVERTING ENZYME | |
3zqz[1] | F |
SLC
SELENO-CAPTOPRIL[14 atoms] |
A | 55.6 /37.7 |
9 /9 |
ACE_DROME ANGIOTENSIN-CONVERTING ENZYME | |
4ca5[1] | J |
3EF
N-{(2S)-3-[(S)-[(1R)-1-{[(benzyloxy)carbonyl]amino.. |
A | 43.5 /43.3 |
23 /23 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
4ca6[2] | O |
3EF
N-{(2S)-3-[(S)-[(1R)-1-{[(benzyloxy)carbonyl]amino.. |
A | 48.0 /43.4 |
25 /25 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME N-DOMAIN | |
4ca7[1] | F |
3EF
N-{(2S)-3-[(S)-[(1R)-1-{[(benzyloxy)carbonyl]amino.. |
A | 44.0 /37.7 |
25 /25 |
ACE_DROME ANGIOTENSIN-CONVERTING ENZYME | |
5a2r[1] | B |
MLT
D-MALATE[9 atoms] |
A | 50.0 /37.7 |
8 /8 |
ACE_DROME ANGIOTENSIN-CONVERTING ENZYME | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
METAL | |||||||
805 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
5am9[4] | U |
NA
SODIUM ION[1 atoms] |
A | 66.7 /43.6 |
3 /3 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
6zpq[1] | RA |
NA
SODIUM ION[1 atoms] |
B | 0.0 /43.6 |
1 /1 |
ACE_HUMAN Angiotensin-converting enzyme | |
7l0n[1] | BB |
NA
SODIUM ION[1 atoms] |
J | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7l0n[1] | YA |
NA
SODIUM ION[1 atoms] |
J | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8byj[1] | G |
NA
SODIUM ION[1 atoms] |
B | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
1o86[28] | E |
CL
CHLORIDE ION[1 atoms] |
A | 80.0 /43.7 |
5 /5 |
ACET_HUMAN ANGIOTENSIN CONVERTING ENZYME | |
1o86[27] | F |
CL
CHLORIDE ION[1 atoms] |
A | 60.0 /43.7 |
5 /5 |
ACET_HUMAN ANGIOTENSIN CONVERTING ENZYME | |
1r42[53] | I |
CL
CHLORIDE ION[1 atoms] |
A | 100.0 /100.0 |
4 /4 |
angiotensin I converting enzyme 2 | |
2c6n[81] | H |
CL
CHLORIDE ION[1 atoms] |
A | 60.0 /44.3 |
5 /5 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME, SOMATIC ISOFORM | |
2xy9[1] | D |
CL
CHLORIDE ION[1 atoms] |
A | 80.0 /43.6 |
5 /5 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
2xy9[1] | E |
CL
CHLORIDE ION[1 atoms] |
A | 60.0 /43.6 |
5 /5 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
6f9v[4] | H |
CL
CHLORIDE ION[1 atoms] |
A | 50.0 /43.5 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
7l0n[1] | FB |
CL
CHLORIDE ION[1 atoms] |
I | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7l0n[2] | GB |
CL
CHLORIDE ION[1 atoms] |
I | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7l0n[1] | AB |
CL
CHLORIDE ION[1 atoms] |
J | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7l0n[1] | CB |
CL
CHLORIDE ION[1 atoms] |
J | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7l0n[1] | DB |
CL
CHLORIDE ION[1 atoms] |
J | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7l0n[1] | EB |
CL
CHLORIDE ION[1 atoms] |
J | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7l0n[2] | XA |
CL
CHLORIDE ION[1 atoms] |
J | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7q3y[2] | L |
CL
CHLORIDE ION[1 atoms] |
A | 33.3 /43.3 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
7u0n[1] | Q |
CL
CHLORIDE ION[1 atoms] |
A | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7u0n[1] | CA |
CL
CHLORIDE ION[1 atoms] |
B | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7u0n[1] | Y |
CL
CHLORIDE ION[1 atoms] |
B | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7whh[7] | E |
CL
CHLORIDE ION[1 atoms] |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8df5[1] | AC |
CL
CHLORIDE ION[1 atoms] |
E | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8df5[2] | SA |
CL
CHLORIDE ION[1 atoms] |
E | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8df5[2] | TA |
CL
CHLORIDE ION[1 atoms] |
E | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8df5[2] | VA |
CL
CHLORIDE ION[1 atoms] |
E | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8df5[1] | JB |
CL
CHLORIDE ION[1 atoms] |
F | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8df5[1] | LB |
CL
CHLORIDE ION[1 atoms] |
F | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7xby[1] | D |
BR
BROMIDE ION[1 atoms] |
A | 100.0 /87.4 |
3 /3 |
F6V9L3_HORSE Angiotensin-converting enzyme | |
7xby[1] | E |
BR
BROMIDE ION[1 atoms] |
A | 100.0 /87.4 |
3 /3 |
F6V9L3_HORSE Angiotensin-converting enzyme | |
7xby[1] | F |
BR
BROMIDE ION[1 atoms] |
A | 100.0 /87.4 |
1 /1 |
F6V9L3_HORSE Angiotensin-converting enzyme | |
7xby[1] | G |
BR
BROMIDE ION[1 atoms] |
A | 100.0 /87.4 |
5 /5 |
F6V9L3_HORSE Angiotensin-converting enzyme | |
7xby[1] | H |
BR
BROMIDE ION[1 atoms] |
A | 100.0 /87.4 |
4 /4 |
F6V9L3_HORSE Angiotensin-converting enzyme | |
1j36[336] | C |
ZN
ZINC ION[1 atoms] |
A | 100.0 /37.6 |
3 /3 |
ACE_DROME angiotensin converting enzyme | |
2xy9[1] | F |
ZN
ZINC ION[1 atoms] |
A | 100.0 /43.6 |
3 /3 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
7pki[5] | N |
ZN
ZINC ION[1 atoms] |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8aqs[1] | I |
ZN
ZINC ION[1 atoms] |
B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8bn1[1] | F |
ZN
ZINC ION[1 atoms] |
A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8ify[1] | TA |
ZN
ZINC ION[1 atoms] |
E | 100.0 /82.4 |
3 /3 |
A0A6J0Z472_ODOVR Angiotensin-converting enzyme | |
8ifz[1] | H |
ZN
ZINC ION[1 atoms] |
B | 66.7 /82.4 |
3 /3 |
A0A6J0Z472_ODOVR Angiotensin-converting enzyme | |
6en5[31] | T |
MG
MAGNESIUM ION[1 atoms] |
A | 66.7 /43.8 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
7u0n[1] | Z |
MG
MAGNESIUM ION[1 atoms] |
B | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
5am9[4] | DA |
CA
CALCIUM ION[1 atoms] |
B | 66.7 /43.6 |
3 /3 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
OTHERPOLY | |||||||
805 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
2ajf[23] | E | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme-Related Carboxypepti.. | |
2xyd[26] | H | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | B | 60.0 /43.4 |
5 /5 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
6en5[4] | N | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | D | 80.0 /43.6 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme | |
6vw1[10] | F | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6zpu[1] | B | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 75.0 /43.2 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
7p8i[3] | F | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7p8i[1] | L | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7q49[4] | E | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 0.0 /44.1 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
7q49[4] | G | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 33.3 /44.1 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
7sn0[1] | F | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7sn0[1] | N | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | B | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7u0n[1] | E | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | B | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7xwa[2] | I | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8hfy[1] | D | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | B | 66.7 /82.4 |
3 /3 |
A0A6J0Z472_ODOVR Angiotensin-converting enzyme | |
2c6f[4] | C | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 33.3 /44.3 |
3 /3 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME, SOMATIC ISOFORM | |
2c6f[2] | D | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 60.0 /44.3 |
5 /5 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME, SOMATIC ISOFORM | |
2xyd[52] | D | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 80.0 /43.4 |
5 /5 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
5am8[42] | J | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 50.0 /43.6 |
6 /6 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
6f9t[133] | B | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 75.0 /43.2 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
6m17[17] | J | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6m17[22] | K | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6m17[12] | M | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6s1y[43] | C | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 0.0 /39.3 |
3 /3 |
A0NFU8_ANOGA Angiotensin-converting enzyme | |
6vw1[83] | I | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7ct5[6] | CA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7ct5[4] | DA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7dmu[2] | G | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /98.8 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7dwx[14] | O | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7dwx[4] | Q | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7kj2[6] | Q | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7kj2[6] | R | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7kj2[6] | U | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7q3y[2] | C | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 50.0 /43.3 |
2 /2 |
ACE_HUMAN Angiotensin-converting enzyme | |
7q3y[2] | D | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 0.0 /43.3 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
7sn0[1] | L | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7wbp[2] | C | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7wpo[2] | E | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 25.0 /78.2 |
4 /4 |
A0A7J7V5I6_PIPKU Angiotensin-converting enzyme | |
7xo6[8] | C | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /84.3 |
3 /3 |
ACE2_MOUSE Angiotensin-converting enzyme 2 | |
7y1y[24] | DA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7y1y[24] | GA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8i93[2] | H | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8i93[2] | J | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
3bkk[4] | B | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 40.0 /43.1 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme, somatic isoform | |
6en5[15] | G | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 25.0 /43.8 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
6h5x[4] | D | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 50.0 /43.6 |
8 /8 |
ACE_HUMAN Angiotensin-converting enzyme | |
7lo4[1] | C | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7wa3[1] | C | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | B | 75.0 /84.1 |
4 /4 |
A0A7T0Q2W2_NEOVI Angiotensin-converting enzyme | |
7wpo[1] | F | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 66.7 /78.2 |
3 /3 |
A0A7J7V5I6_PIPKU Angiotensin-converting enzyme | |
7yhw[2] | D | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8e7m[1] | D | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8e7m[1] | E | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8h5c[1] | D | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 100.0 /100.0 |
7 /7 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8tor[1] | C | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6vw1[3] | J | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-3)-bet.. | B | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7dmu[2] | H | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | A | 100.0 /98.8 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7dmu[3] | J | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | C | 100.0 /98.8 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7q49[1] | C | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | A | 40.0 /44.1 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme | |
7sn0[2] | E | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | A | 100.0 /100.0 |
8 /8 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8iou[8] | N | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | D | 100.0 /100.0 |
7 /7 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8jje[1] | F | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | A | 100.0 /99.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7q3y[2] | B | alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. | A | 60.0 /43.3 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme | |
7xwa[1] | J | alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. | C | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7sn0[1] | H | beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b.. | A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7sn0[1] | I | beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b.. | A | 100.0 /100.0 |
7 /7 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7sn0[1] | K | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp.. | B | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7sn0[1] | M | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-alp.. | B | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7sn0[1] | O | beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-b.. | B | 100.0 /100.0 |
8 /8 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7whh[1] | C | alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-be.. | A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8if2[1] | D | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7dmu[1] | E | alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. | A | 100.0 /98.8 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8jje[1] | C | alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. | A | 100.0 /99.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
2xyd[51] | C | alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. | A | 25.0 /43.4 |
4 /5 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
7f5r[1] | H | alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. | A | 75.0 /84.1 |
4 /4 |
mink ACE2 | |
7fc3[1] | C | alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. | B | 100.0 /87.4 |
4 /4 |
F6V9L3_HORSE Angiotensin-converting enzyme | |
8qfx[2] | J | alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. | A | 25.0 /43.7 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme, soluble form | |
8t23[1] | D | alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. | A | 50.0 /84.2 |
6 /6 |
A0A7T0Q2W2_NEOVI Angiotensin-converting enzyme | |
8tos[1] | C | alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8tos[1] | D | alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8vqr[1] | E | alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. | A | 85.7 /96.1 |
7 /7 |
B4XEP4_NYCPR ACE2_HUMAN B4XEP4_NYCPR ACE2_HUMAN B4XE Angiotensin-converting enzyme,Processed angiotensi.. | |
8vqr[1] | F | beta-D-mannopyranose-(1-4)-beta-D-mannopyranose-(1.. | A | 100.0 /96.1 |
13 /13 |
B4XEP4_NYCPR ACE2_HUMAN B4XEP4_NYCPR ACE2_HUMAN B4XE Angiotensin-converting enzyme,Processed angiotensi.. | |
6tt4[1] | F | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | B | 60.0 /43.3 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme | |
7q28[3] | B | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | A | 33.3 /43.2 |
6 /6 |
ACE_HUMAN Angiotensin-converting enzyme | |
8vqr[1] | J | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | B | 100.0 /95.8 |
15 /15 |
B4XEP4_NYCPR ACE2_HUMAN B4XEP4_NYCPR ACE2_HUMAN B4XE Angiotensin-converting enzyme,Processed angiotensi.. | |
7q4d[3] | E | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | A | 75.0 /44.1 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
7ufk[2] | I | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | B | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8vqr[1] | H | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | B | 100.0 /95.8 |
3 /3 |
B4XEP4_NYCPR ACE2_HUMAN B4XEP4_NYCPR ACE2_HUMAN B4XE Angiotensin-converting enzyme,Processed angiotensi.. | |
7wsk[1] | C | alpha-D-mannopyranose-(1-3)-2-acetamido-2-deoxy-be.. | A | 100.0 /85.2 |
4 /4 |
ACE2_PAGLA Processed angiotensin-converting enzyme 2 | |
6en5[1] | O | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | D | 60.0 /43.6 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme | |
7q49[1] | B | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | A | 40.0 /44.1 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme | |
7q4d[3] | C | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp.. | A | 25.0 /44.1 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
7q4d[3] | F | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp.. | A | 37.5 /44.1 |
8 /8 |
ACE_HUMAN Angiotensin-converting enzyme | |
5am9[2] | G | alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. | A | 50.0 /43.6 |
6 /6 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
2xy9[1] | B | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 40.0 /43.6 |
5 /5 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
2xyd[31] | E | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 60.0 /43.4 |
5 /5 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
4bzr[6] | B | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 42.9 /43.6 |
7 /7 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
7xb1[1] | D | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /100.0 |
9 /9 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
5am8[2] | P | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 60.0 /43.6 |
5 /5 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
5am8[2] | Q | alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. | D | 40.0 /43.5 |
5 /5 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
5am9[1] | E | beta-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta.. | A | 60.0 /43.6 |
5 /5 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
6f9u[1] | B | alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. | A | 42.9 /43.1 |
7 /7 |
ACE_HUMAN Angiotensin-converting enzyme | |
6f9v[1] | C | alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. | A | 50.0 /43.5 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
2iul[1] | B | beta-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1.. | A | 42.9 /43.2 |
7 /7 |
ACET_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
6f9t[2] | C | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alp.. | A | 36.4 /43.2 |
11 /11 |
ACE_HUMAN Angiotensin-converting enzyme | |
2x8y[18] | B | beta-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(.. | A | 0.0 /37.7 |
3 /3 |
ACE_DROME ANGIOTENSIN CONVERTING ENZYME | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
HOMO | |||||||
805 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
3d0g[3] | B | ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2[597 aa] | A | 100.0 /98.5 |
2 /2 |
ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2 | |
3d0g[3] | A | ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2[597 aa] | B | 100.0 /98.5 |
3 /3 |
ACE2_PAGLA ACE2_HUMAN Angiotensin-converting enzyme 2 | |
3kbh[4] | E | ACE2_HUMAN Angiotensin-converting enzyme 2[593 aa] | A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6m17[18] | E | ACE2_HUMAN Angiotensin-converting enzyme 2[748 aa] | B | 100.0 /100.0 |
26 /26 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7l7f[2] | C | ACE2_HUMAN Angiotensin-converting enzyme 2[711 aa] | A | 100.0 /100.0 |
21 /21 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8bfw[2] | C | ACE2_HUMAN Processed angiotensin-converting enzyme 2[591 aa] | A | 100.0 /100.0 |
17 /17 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8i93[2] | C | ACE2_HUMAN Angiotensin-converting enzyme 2[749 aa] | A | 100.0 /100.0 |
22 /22 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
PRECIPITANT | |||||||
805 | pdb_id | contact mol | homologue | ||||
a3 | description | a4 | identity[%]5 | Ncon6 | description | ||
2c6f[3] | N |
GOL
GLYCEROL[6 atoms] |
A | 40.0 /44.3 |
5 /5 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME, SOMATIC ISOFORM | |
2c6n[1] | J |
GOL
GLYCEROL[6 atoms] |
A | 0.0 /44.3 |
1 /1 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME, SOMATIC ISOFORM | |
3bkl[1] | L |
GOL
GLYCEROL[6 atoms] |
A | 20.0 /43.1 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme, somatic isoform | |
4c2p[1] | H |
GOL
GLYCEROL[6 atoms] |
A | 66.7 /43.4 |
3 /3 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
8asy[1] | C |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8asy[1] | E |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8asy[1] | K |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8asy[1] | M |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8asy[1] | N |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8asy[1] | O |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8asy[1] | P |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8asy[1] | Q |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
7 /7 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8asy[1] | S |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8asy[1] | T |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
8 /8 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8asy[1] | U |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
1 /1 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8tor[2] | E |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8tor[1] | G |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
6 /6 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8tor[2] | H |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8tos[1] | H |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8tos[1] | I |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8tos[1] | J |
GOL
GLYCEROL[6 atoms] |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
5a2r[1] | F |
TRS
2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL[8 atoms] |
A | 42.9 /37.7 |
7 /7 |
ACE_DROME ANGIOTENSIN-CONVERTING ENZYME | |
7pki[1] | K |
TRS
2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL[8 atoms] |
A | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
4apj[1] | E |
SO4
SULFATE ION[5 atoms] |
A | 33.3 /43.6 |
3 /3 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
4c2n[4] | F |
SO4
SULFATE ION[5 atoms] |
A | 85.7 /43.6 |
7 /7 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
4ca8[1] | D |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /37.7 |
1 /1 |
ACE_DROME ANGIOTENSIN-CONVERTING ENZYME | |
4ca8[1] | F |
SO4
SULFATE ION[5 atoms] |
A | 25.0 /37.7 |
4 /4 |
ACE_DROME ANGIOTENSIN-CONVERTING ENZYME | |
4ca8[1] | G |
SO4
SULFATE ION[5 atoms] |
A | 40.0 /37.7 |
5 /5 |
ACE_DROME ANGIOTENSIN-CONVERTING ENZYME | |
5am8[4] | T |
SO4
SULFATE ION[5 atoms] |
A | 0.0 /43.6 |
2 /2 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
7dmu[2] | P |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /98.8 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
7pki[1] | H |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /100.0 |
2 /2 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7pki[1] | I |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7pki[1] | J |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
8jje[1] | J |
SO4
SULFATE ION[5 atoms] |
A | 100.0 /99.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6en5[3] | AA |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 50.0 /43.8 |
2 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en5[7] | BA |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 0.0 /43.8 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en5[20] | CA |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 0.0 /43.8 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en5[64] | DA |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /43.8 |
1 /1 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en5[15] | X |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 60.0 /43.8 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en5[1] | Z |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 66.7 /43.8 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en5[5] | TA |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 33.3 /43.7 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en5[1] | UA |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 0.0 /43.7 |
2 /2 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en5[5] | FB |
EDO
1,2-ETHANEDIOL[4 atoms] |
C | 50.0 /43.7 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en5[3] | GB |
EDO
1,2-ETHANEDIOL[4 atoms] |
C | 0.0 /43.7 |
1 /1 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en5[13] | HB |
EDO
1,2-ETHANEDIOL[4 atoms] |
C | 50.0 /43.7 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en5[2] | IB |
EDO
1,2-ETHANEDIOL[4 atoms] |
C | 0.0 /43.7 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en5[4] | UB |
EDO
1,2-ETHANEDIOL[4 atoms] |
D | 20.0 /43.6 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en5[7] | WB |
EDO
1,2-ETHANEDIOL[4 atoms] |
D | 33.3 /43.6 |
3 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en6[1] | W |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /43.8 |
1 /1 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en6[4] | KA |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 50.0 /43.7 |
8 /8 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en6[1] | LA |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 0.0 /43.7 |
1 /1 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en6[1] | NA |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 0.0 /43.7 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en6[1] | HB |
EDO
1,2-ETHANEDIOL[4 atoms] |
C | 33.3 /43.7 |
3 /5 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en6[2] | IB |
EDO
1,2-ETHANEDIOL[4 atoms] |
C | 0.0 /43.7 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en6[1] | UB |
EDO
1,2-ETHANEDIOL[4 atoms] |
D | 100.0 /43.7 |
1 /1 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en6[1] | YB |
EDO
1,2-ETHANEDIOL[4 atoms] |
D | 60.0 /43.7 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme | |
6f9r[1] | AA |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 40.0 /43.5 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme | |
6f9t[1] | K |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 60.0 /43.2 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme | |
6f9t[2] | L |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 25.0 /43.2 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
6f9u[1] | L |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 0.0 /43.1 |
2 /2 |
ACE_HUMAN Angiotensin-converting enzyme | |
6f9u[8] | M |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 50.0 /43.1 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
6f9u[3] | P |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 50.0 /43.1 |
2 /2 |
ACE_HUMAN Angiotensin-converting enzyme | |
6f9v[3] | M |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 66.7 /43.5 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
6h5w[1] | P |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 37.5 /43.2 |
8 /8 |
ACE_HUMAN Angiotensin-converting enzyme | |
6h5w[2] | R |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 33.3 /43.2 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
6h5x[1] | T |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 0.0 /43.6 |
4 /6 |
ACE_HUMAN Angiotensin-converting enzyme | |
6s1y[1] | E |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /39.3 |
2 /2 |
A0NFU8_ANOGA Angiotensin-converting enzyme | |
6tt3[1] | FA |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 50.0 /43.3 |
8 /9 |
ACE_HUMAN Angiotensin-converting enzyme | |
6tt4[3] | AA |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 0.0 /43.3 |
2 /2 |
ACE_HUMAN Angiotensin-converting enzyme | |
6vw1[8] | T |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 100.0 /100.0 |
9 /9 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
6zpq[2] | U |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 25.0 /43.6 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
6zpq[2] | HB |
EDO
1,2-ETHANEDIOL[4 atoms] |
D | 100.0 /43.6 |
1 /1 |
ACE_HUMAN Angiotensin-converting enzyme | |
6zpu[3] | G |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /43.2 |
2 /2 |
ACE_HUMAN Angiotensin-converting enzyme | |
7lo4[1] | H |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /100.0 |
3 /3 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7lo4[1] | I |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /100.0 |
7 /7 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
7q24[2] | Y |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 25.0 /43.4 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
7q27[4] | D |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 50.0 /43.1 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
7q27[1] | F |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 75.0 /43.1 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
7z6z[1] | WA |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 50.0 /43.6 |
2 /4 |
ACE_HUMAN Angiotensin-converting enzyme, soluble form | |
7z6z[1] | YA |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 0.0 /43.6 |
2 /2 |
ACE_HUMAN Angiotensin-converting enzyme, soluble form | |
7z70[1] | J |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 100.0 /43.5 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme | |
8df5[2] | QA |
EDO
1,2-ETHANEDIOL[4 atoms] |
E | 100.0 /100.0 |
4 /4 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8qfx[1] | Y |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 0.0 /43.7 |
1 /3 |
ACE_HUMAN Angiotensin-converting enzyme, soluble form | |
8qfx[1] | Z |
EDO
1,2-ETHANEDIOL[4 atoms] |
A | 0.0 /43.7 |
1 /4 |
ACE_HUMAN Angiotensin-converting enzyme, soluble form | |
8qfx[1] | BC |
EDO
1,2-ETHANEDIOL[4 atoms] |
D | 33.3 /43.6 |
6 /6 |
ACE_HUMAN Angiotensin-converting enzyme, soluble form | |
8qfx[1] | FC |
EDO
1,2-ETHANEDIOL[4 atoms] |
D | 100.0 /43.6 |
1 /1 |
ACE_HUMAN Angiotensin-converting enzyme, soluble form | |
8vqr[1] | Q |
EDO
1,2-ETHANEDIOL[4 atoms] |
B | 100.0 /95.8 |
3 /3 |
B4XEP4_NYCPR ACE2_HUMAN B4XEP4_NYCPR ACE2_HUMAN B4XE Angiotensin-converting enzyme,Processed angiotensi.. | |
1o8a[5] | H |
ACT
ACETATE ION[4 atoms] |
A | 83.3 /43.7 |
6 /6 |
ACET_HUMAN ANGIOTENSIN CONVERTING ENZYME | |
2c6f[1] | L |
ACT
ACETATE ION[4 atoms] |
A | 0.0 /44.3 |
2 /2 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME, SOMATIC ISOFORM | |
2c6f[2] | M |
ACT
ACETATE ION[4 atoms] |
A | 40.0 /44.3 |
5 /5 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME, SOMATIC ISOFORM | |
2iul[6] | E |
ACT
ACETATE ION[4 atoms] |
A | 50.0 /43.2 |
6 /6 |
ACET_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
2xy9[1] | C |
ACT
ACETATE ION[4 atoms] |
A | 42.9 /43.6 |
7 /7 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
3bkl[1] | H |
ACT
ACETATE ION[4 atoms] |
A | 11.1 /43.1 |
9 /9 |
ACE_HUMAN Angiotensin-converting enzyme, somatic isoform | |
3bkl[1] | I |
ACT
ACETATE ION[4 atoms] |
A | 66.7 /43.1 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme, somatic isoform | |
3bkl[1] | J |
ACT
ACETATE ION[4 atoms] |
A | 75.0 /43.1 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme, somatic isoform | |
4aph[5] | K |
ACT
ACETATE ION[4 atoms] |
A | 33.3 /43.6 |
3 /3 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
4aph[2] | L |
ACT
ACETATE ION[4 atoms] |
A | 40.0 /43.6 |
5 /5 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
4aph[3] | M |
ACT
ACETATE ION[4 atoms] |
A | 75.0 /43.6 |
4 /4 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
4c2p[3] | G |
ACT
ACETATE ION[4 atoms] |
A | 42.9 /43.4 |
7 /7 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
6en5[19] | EA |
ACT
ACETATE ION[4 atoms] |
A | 66.7 /43.8 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en5[8] | FA |
ACT
ACETATE ION[4 atoms] |
A | 50.0 /43.8 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en6[2] | KB |
ACT
ACETATE ION[4 atoms] |
C | 50.0 /43.7 |
2 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
6f9r[1] | P |
ACT
ACETATE ION[4 atoms] |
A | 0.0 /43.4 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
7q24[1] | Z |
ACT
ACETATE ION[4 atoms] |
B | 0.0 /43.4 |
2 /2 |
ACE_HUMAN Angiotensin-converting enzyme | |
7q27[1] | G |
ACT
ACETATE ION[4 atoms] |
A | 60.0 /43.1 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme | |
7z6z[2] | W |
ACT
ACETATE ION[4 atoms] |
A | 0.0 /43.6 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme, soluble form | |
7z6z[1] | JA |
ACT
ACETATE ION[4 atoms] |
B | 50.0 /43.6 |
2 /2 |
ACE_HUMAN Angiotensin-converting enzyme, soluble form | |
7z6z[1] | LA |
ACT
ACETATE ION[4 atoms] |
B | 50.0 /43.6 |
2 /2 |
ACE_HUMAN Angiotensin-converting enzyme, soluble form | |
7z6z[1] | MA |
ACT
ACETATE ION[4 atoms] |
B | 33.3 /43.6 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme, soluble form | |
8qfx[1] | NB |
ACT
ACETATE ION[4 atoms] |
C | 33.3 /43.6 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme, soluble form | |
2xyd[56] | L |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /43.4 |
2 /2 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
2xyd[2] | M |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 0.0 /43.4 |
2 /2 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
2xyd[39] | N |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 0.0 /43.4 |
4 /4 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
4bxk[11] | I |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 50.0 /43.4 |
2 /2 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
4bxk[22] | R |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
B | 50.0 /43.4 |
2 /2 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
4ca5[2] | I |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 60.0 /43.3 |
5 /5 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
4ca6[5] | N |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 12.5 /43.4 |
8 /8 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME N-DOMAIN | |
4ufa[10] | R |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
B | 0.0 /43.4 |
2 /2 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
5am8[5] | AB |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
D | 100.0 /43.5 |
4 /4 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
5am8[4] | XA |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
D | 0.0 /43.5 |
1 /1 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
5amb[2] | M |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 33.3 /43.4 |
6 /6 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
6en5[1] | W |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 20.0 /43.8 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en5[1] | DB |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
C | 60.0 /43.7 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en6[1] | SB |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
D | 33.3 /43.7 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
6f9t[1] | N |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 20.0 /43.2 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme | |
6f9t[1] | O |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /43.2 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme | |
6f9u[1] | R |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 40.0 /43.1 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme | |
6qs1[1] | BA |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
B | 50.0 /43.6 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
6qs1[1] | CA |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
B | 50.0 /43.6 |
6 /6 |
ACE_HUMAN Angiotensin-converting enzyme | |
6s1y[1] | D |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 33.3 /39.3 |
3 /4 |
A0NFU8_ANOGA Angiotensin-converting enzyme | |
6zpq[1] | MA |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
B | 16.7 /43.6 |
6 /6 |
ACE_HUMAN Angiotensin-converting enzyme | |
7q29[1] | J |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 100.0 /43.2 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
7z6z[1] | T |
PEG
DI(HYDROXYETHYL)ETHER[7 atoms] |
A | 66.7 /43.6 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme, soluble form | |
2xyd[14] | O |
PG4
TETRAETHYLENE GLYCOL[10 atoms] |
A | 0.0 /43.4 |
4 /4 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
2xyd[5] | S |
PG4
TETRAETHYLENE GLYCOL[13 atoms] |
B | 50.0 /43.4 |
4 /4 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
6en5[2] | XA |
PG4
TETRAETHYLENE GLYCOL[13 atoms] |
B | 25.0 /43.7 |
8 /8 |
ACE_HUMAN Angiotensin-converting enzyme | |
7q24[4] | W |
PG4
TETRAETHYLENE GLYCOL[13 atoms] |
B | 83.3 /43.4 |
6 /6 |
ACE_HUMAN Angiotensin-converting enzyme | |
8qfx[1] | GB |
PG4
TETRAETHYLENE GLYCOL[13 atoms] |
C | 11.1 /43.6 |
9 /9 |
ACE_HUMAN Angiotensin-converting enzyme, soluble form | |
8qhl[1] | Q |
PG4
TETRAETHYLENE GLYCOL[13 atoms] |
A | 50.0 /43.6 |
6 /6 |
ACE_HUMAN Angiotensin-converting enzyme | |
6f9u[3] | G |
1PE
PENTAETHYLENE GLYCOL[16 atoms] |
A | 30.0 /43.1 |
10 /10 |
ACE_HUMAN Angiotensin-converting enzyme | |
7q25[3] | J |
1PE
PENTAETHYLENE GLYCOL[16 atoms] |
A | 75.0 /43.5 |
8 /9 |
ACE_HUMAN Angiotensin-converting enzyme | |
7q26[1] | AA |
1PE
PENTAETHYLENE GLYCOL[16 atoms] |
B | 0.0 /43.7 |
7 /7 |
ACE_HUMAN Angiotensin-converting enzyme | |
8qhl[1] | AA |
1PE
PENTAETHYLENE GLYCOL[16 atoms] |
C | 0.0 /43.6 |
2 /2 |
ACE_HUMAN Angiotensin-converting enzyme | |
8qhl[1] | BA |
1PE
PENTAETHYLENE GLYCOL[16 atoms] |
C | 40.0 /43.6 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme | |
6zpq[1] | KA |
MXE
2-METHOXYETHANOL[5 atoms] |
B | 0.0 /43.6 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
6zpq[1] | TA |
MXE
2-METHOXYETHANOL[5 atoms] |
C | 50.0 /43.6 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en5[9] | WA |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
B | 0.0 /43.7 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en6[1] | Z |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
A | 22.2 /43.8 |
9 /9 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en6[1] | UA |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
B | 12.5 /43.7 |
8 /8 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en6[1] | VA |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
B | 0.0 /43.7 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en6[1] | IC |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
D | 20.0 /43.7 |
5 /6 |
ACE_HUMAN Angiotensin-converting enzyme | |
6en6[1] | JC |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
D | 33.3 /43.7 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
6f9t[1] | Q |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
A | 40.0 /43.2 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme | |
6f9v[3] | DA |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
B | 0.0 /43.6 |
1 /1 |
ACE_HUMAN Angiotensin-converting enzyme | |
6h5x[2] | DA |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
B | 12.5 /43.4 |
8 /8 |
ACE_HUMAN Angiotensin-converting enzyme | |
6tt3[1] | N |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
A | 33.3 /43.3 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
6tt4[6] | W |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
B | 25.0 /43.3 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
6zpq[5] | R |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
A | 80.0 /43.6 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme | |
6zpq[1] | HA |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
B | 40.0 /43.6 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme | |
7l0n[1] | PA |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
I | 100.0 /100.0 |
5 /5 |
ACE2_HUMAN Angiotensin-converting enzyme 2 | |
8asy[1] | R |
PGE
TRIETHYLENE GLYCOL[10 atoms] |
A | 100.0 /100.0 |
9 /9 |
ACE2_HUMAN Processed angiotensin-converting enzyme 2 | |
2x90[6] | C |
EPE
4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACI.. |
A | 33.3 /37.7 |
6 /6 |
ACE_DROME ANGIOTENSIN CONVERTING ENZYME | |
2x90[5] | D |
EPE
4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACI.. |
A | 100.0 /37.7 |
3 /3 |
ACE_DROME ANGIOTENSIN CONVERTING ENZYME | |
2x91[2] | F |
EPE
4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACI.. |
A | 25.0 /37.7 |
8 /8 |
ACE_DROME ANGIOTENSIN CONVERTING ENZYME | |
2xhm[1] | E |
EPE
4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACI.. |
A | 54.5 /37.7 |
11 /11 |
ACE_DROME ANGIOTENSIN CONVERTING ENZYME | |
2xy9[1] | H |
EPE
4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACI.. |
A | 33.3 /43.6 |
6 /6 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
6f9t[6] | H |
IMD
IMIDAZOLE[5 atoms] |
A | 42.9 /43.2 |
7 /7 |
ACE_HUMAN Angiotensin-converting enzyme | |
6f9t[1] | I |
IMD
IMIDAZOLE[5 atoms] |
A | 75.0 /43.2 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
6f9u[1] | J |
IMD
IMIDAZOLE[5 atoms] |
A | 0.0 /43.1 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
6f9t[4] | J |
BO3
BORIC ACID[4 atoms] |
A | 100.0 /43.2 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
6f9u[4] | I |
BO3
BORIC ACID[4 atoms] |
A | 62.5 /43.1 |
8 /8 |
ACE_HUMAN Angiotensin-converting enzyme | |
6h5w[1] | K |
BO3
BORIC ACID[4 atoms] |
A | 0.0 /43.2 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
6qs1[3] | N |
BO3
BORIC ACID[4 atoms] |
A | 50.0 /43.5 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
6qs1[13] | O |
BO3
BORIC ACID[4 atoms] |
A | 66.7 /43.5 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
6qs1[2] | U |
BO3
BORIC ACID[4 atoms] |
A | 0.0 /43.5 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
6qs1[2] | EA |
BO3
BORIC ACID[4 atoms] |
B | 66.7 /43.6 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
6tt3[2] | J |
BO3
BORIC ACID[4 atoms] |
A | 0.0 /43.3 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
6tt4[4] | S |
BO3
BORIC ACID[4 atoms] |
A | 75.0 /43.4 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
6zpq[1] | N |
BO3
BORIC ACID[4 atoms] |
A | 33.3 /43.6 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
6zpq[1] | UA |
BO3
BORIC ACID[4 atoms] |
C | 66.7 /43.6 |
3 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
6zpq[1] | JB |
BO3
BORIC ACID[4 atoms] |
D | 50.0 /43.6 |
2 /3 |
ACE_HUMAN Angiotensin-converting enzyme | |
7q27[4] | M |
BO3
BORIC ACID[4 atoms] |
A | 50.0 /43.1 |
6 /6 |
ACE_HUMAN Angiotensin-converting enzyme | |
7q27[1] | O |
BO3
BORIC ACID[4 atoms] |
A | 0.0 /43.1 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
7q28[2] | H |
BO3
BORIC ACID[4 atoms] |
A | 0.0 /43.2 |
5 /5 |
ACE_HUMAN Angiotensin-converting enzyme | |
7q28[2] | J |
BO3
BORIC ACID[4 atoms] |
A | 75.0 /43.2 |
4 /4 |
ACE_HUMAN Angiotensin-converting enzyme | |
6f9v[3] | FA |
P33
3,6,9,12,15,18-HEXAOXAICOSANE-1,20-DIOL[22 atoms] |
B | 33.3 /43.6 |
6 /6 |
ACE_HUMAN Angiotensin-converting enzyme | |
1o86[2] | B |
GLY
GLYCINE[4 atoms] |
A | 0.0 /43.7 |
5 /5 |
ACET_HUMAN ANGIOTENSIN CONVERTING ENZYME | |
5amc[2] | I |
GLY
GLYCINE[4 atoms] |
A | 83.3 /43.6 |
6 /6 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
2xyd[16] | T |
P6G
HEXAETHYLENE GLYCOL[19 atoms] |
B | 33.3 /43.4 |
3 /3 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
3nxq[6] | K |
P6G
HEXAETHYLENE GLYCOL[13 atoms] |
A | 22.2 /43.4 |
9 /9 |
ACE_HUMAN Angiotensin-converting enzyme | |
4ufa[12] | L |
P6G
HEXAETHYLENE GLYCOL[19 atoms] |
A | 55.6 /43.4 |
9 /9 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
6h5w[1] | N |
P6G
HEXAETHYLENE GLYCOL[19 atoms] |
A | 55.6 /43.2 |
9 /9 |
ACE_HUMAN Angiotensin-converting enzyme | |
4aph[7] | G |
PE4
2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}.. |
A | 25.0 /43.6 |
8 /8 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
4apj[1] | I |
PE4
2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}.. |
A | 25.0 /43.6 |
4 /4 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
4apj[1] | J |
PE4
2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}.. |
A | 44.4 /43.6 |
9 /10 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
4bzs[1] | K |
PE4
2-{2-[2-(2-{2-[2-(2-ETHOXY-ETHOXY)-ETHOXY]-ETHOXY}.. |
A | 50.0 /44.1 |
4 /4 |
ACE_HUMAN ANGIOTENSIN-CONVERTING ENZYME | |
2x8y[1] | C |
FLC
CITRATE ANION[13 atoms] |
A | 50.0 /37.7 |
10 /10 |
ACE_DROME ANGIOTENSIN CONVERTING ENZYME | |
4asq[2] | G |
FLC
CITRATE ANION[13 atoms] |
A | 66.7 /37.7 |
6 /6 |
ACE_DROME ANGIOTENSIN-CONVERTING ENZYME | |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. |